Explore more publications!

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on September 19, 2025

2025  Buying Guide—Best Functional Mushroom Supplement 2025 – Brain, Weight Loss, Gut Health, Energy, -MushCanyon Adaptogens Lineup 2025
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
维泰瑞隆入选 2025 年 Endpoints 11 最具潜力生物科技初创企业榜单
Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups
維泰瑞隆入選 2025 年 Endpoints 11 最具潛力生物科技初創企業榜單
Signature HealthCARE Committed to Proactive Resident Safety with SafeSpace Global Corporation
CrazyBulk 2025 | D-BAL, Testo-max , Trenorol , Ultimate Stack Legal Steroids Alternatives launch BY CrazyBulk In USA.
MomentMD Expands Virtual Clinical Education Platform Amid Growing Provider Shortages and Clinical Rotation Crisis
Sonnet to Present at the MedInvest Biotech & Pharma Conference
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
NTA Implant: Solidifying Global Leadership with MDR Certification and Launching a New Era in Implantology
IMUNON to Present New Translational Data of IMNN-001 Supporting Phase 3 Trial of Immunotherapy for Ovarian Cancer at AACR Special Conference in Cancer Research
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Parma in Ohio, Expanding its Statewide Retail Footprint
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
Iterum Therapeutics Provides Business Update
Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
Vaxart Announces Withdrawal of Reverse Stock Split Proposal
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions